Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Ovagen and BAC Water Mix

Ovagen Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Ovagen Titration Schedule

ItemDetails
Standard dose200–600 mcg SC daily; oral 10–20 mg/day
Courses10–20 days, 2–3× per year
Originator dose10–1000× lower (Russian tradition)

Community injectable standard is 10–20 mg/wk — the listed 1–5 mg span undershoots it for once format. The '1–5 mg per dose' figure is a recurring placeholder that never matched a validated protocol for any bioregulator; sources disagree up to 1000× on real doses.

Possible vial strengths:

What Is It?

Ovagen

Liver bioregulator peptide.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Ovagen

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Ovagen Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Ovagen is a Khavinson "bioregulator" — a synthetic tripeptide (Glu-Asp-Leu, EDL) developed in Russia to target the liver and gut lining at the gene level. Despite the "ova-" prefix, it is a liver-first peptide, not an ovarian one, and it's described as steadying how liver and intestinal cells run their detox and barrier genes. It's sold as an oral/sublingual form and as a research-grade injectable powder.
No on both counts. Ovagen (this peptide) has nothing to do with Ovago, the flight-booking website, despite the near-identical spelling — if you're checking whether a travel site is legit, this isn't that page. And although the name sounds ovarian, Ovagen is a liver-gut bioregulator, not a fertility drug; separate "Ovagen"-branded fertility tablets exist and are unrelated to this Khavinson peptide.
In preclinical studies, Ovagen is reported to protect the liver against toxins like carbon tetrachloride and paracetamol, normalize detox-enzyme genes (cytochrome P450, glutathione S-transferases), improve albumin production in aged liver, and restore gut-barrier integrity markers. The theme is the liver-gut axis — supporting both organs at the gene-expression level. This is preclinical, largely Russian research, so it is not a proven treatment for liver or digestive disease.
Only the injectable research powder is reconstituted — the oral or sublingual form is taken directly. For a 20 mg vial, adding 8 mL of bacteriostatic water gives 2.5 mg/mL, so a 500 mcg amount draws to 0.2 mL (20 units on a U-100 syringe); use less water for a stronger concentration. Khavinson gut-liver courses are short and pulsed, and no injectable human dose is formally established, so any figure is a research choice.
Ovagen has no FDA approval and isn't a medicine in the West — it's a research compound or Russian-market supplement, and its safety impression comes only from Khavinson-affiliated work, without independent Western validation. A small tripeptide is expected to be low-toxicity, but liver toxin exposure, hepatitis, or gut disease are serious and need real diagnosis rather than an unproven peptide. Storage: keep the lyophilized powder cold, dry, and out of light; once reconstituted, refrigerate it and use within a few days.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides